Avoid routine azithromycin use in pediatric asthma management. Current evidence doesn’t support its widespread application for asthma exacerbations or prophylaxis.
Focus on established asthma control strategies: regular inhaled corticosteroids, as-needed bronchodilators, and allergy management. These remain the cornerstone of effective treatment. For persistent asthma, consider adding long-acting beta-agonists, or biologics as guided by specialist recommendations.
Reserve azithromycin for specific situations, such as treating co-existing bacterial infections definitively diagnosed via culture or clinical presentation. Always consider alternative antibiotics first, guided by local antimicrobial stewardship guidelines and culture results. Closely monitor patients for potential side effects, including gastrointestinal issues and QT interval prolongation.
Remember: Azithromycin is not a replacement for appropriate asthma control therapy. It addresses bacterial infection, not the underlying inflammatory process of asthma. Individualized treatment plans based on a patient’s specific clinical presentation and history are always recommended. Consult with a pulmonologist or allergist for complex cases.
